Product
Supplier
Encyclopedia
Inquiry
1,3-Dioxo-2-isoindolineaceticacid buy - large image1
1,3-Dioxo-2-isoindolineaceticacid buy - image1
1,3-Dioxo-2-isoindolineaceticacid buy - image2

1,3-Dioxo-2-isoindolineaceticacid

Unit Price: Get Latest Price
CAS No.:

6296-53-3

Grade:

Pharmaceutical Grade

Content:

99%

Packaging:

5KG;1KG

Price valid (until):

2024-08-08

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Avibactam Sodium,Blonanserin,Relebactam,Tofacitinib

  • Product Description

  • Seller Information

  • Description


      Product Detail  


    3-Acetylaminophthalic Anhydride is used in the synthesis of Apremilast, a potent phosphodiesterase 4 and tumor necrosis Factor-α inhibitor used in the treatment of psoriatic arthritis. Also a reagent in the preparation of Tillivalline. Apremilast Impurity 2

    Basic Info
    Product Name:

    N-(1,3-Dioxo-1,3- dihydro-2-benzofuran-4-yl)acetam

    Other Name:

    3-Acetamidophthalic anhydride;N-(1,3-Dioxo-1,3-dihydroisobenzofuran-4-yl)acetamide;3-Acetylaminophthalic Anhydride;Acetamide, N-(1,3-dihydro-1,3-dioxo-4-isobenzofuranyl)-;MFCD00453138;N-(1,3-Dioxo-4-isobenzofuranyl)acetamide;N-(1,3-dioxo-2-benzofuran-4-yl)acetamide;N-(1,3-Dihydro-1,3-dioxoisobenzofuran-4-yl)acetamide;NSC16261;3-acetamidopthalic anhydride

    CAS No.:

    6296-53-3

    Molecular Formula:

    C10H7NO4

    InChIKeys:

    PAUAJOABXCGLCN-UHFFFAOYSA-N

    Molecular Weight:

    205.17

    Exact Mass:

    205.037506

    NSC Number:

    17048|16261

    Categories:

    Immunological Agents

    Characteristics
    PSA:

    72.5

    XLogP3:

    1

    Density:

    1.5±0.1 g/cm3

    Melting Point:

    185-186℃

    Flash Point:

    249.6±24.0 °C

    Refractive Index:

    1.658

    Hazard Identification

    Classification of the substance or mixture

    Skin irritation, Category 2

    Eye irritation, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H315 Causes skin irritation

    H319 Causes serious eye irritation

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P302+P352 IF ON SKIN: Wash with plenty of water/...

    P321 Specific treatment (see ... on this label).

    P332+P317 If skin irritation occurs: Get medical help.

    P362+P364 Take off contaminated clothing and wash it before reuse.

    P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

    Storage

    none

    Disposal

    none

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Avibactam Sodium,Blonanserin,Relebactam,Tofacitinib

    Location:

    2F Building 10, Zhuhai International Health Port, 628 Airport West Road, Sanzao Town, Jinwan District, Zhuhai, Guangdong, China 519090

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    14

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    101-200

    Year of Establishment:

    2012

    Certifications:

    CERTIFICATE OF REGISTRATION

    NewRoute Pharmaceutical Technology Co., Ltd

    NewRoute Pharma  located in Zhuhai, Guangdon Province, is an innovation-oriented enterprise who engages in R&D, production and sales of API, intermediates, formulations and impurity standards.

    Since its establishment in 2012 , the company has maintained a leading momentum in the field of new drug development . Specialized in new drug technology development and achievement transfer , our company is capable of providing other enterprises with various new drug R&D , production and supporting services , which is the reason for many pharmaceutical enterprises to establish strategic cooperation with us .

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.